Podcast
MSL Talk: Tom Caravela, Alyson Evans
KPIs: Why Quantitative WON’T Work Without Qualitative Outcomes
Summary
In this episode, Linda Traylor and Rena Patel join Tom Caravela to share their insights on the evolving landscape of the MSL profession. They discuss the significance of networking, understanding KPIs, and the integration of qualitative outcomes to measure MSL value. The conversation highlights the adaptation of KPIs due to COVID-19 and the shift towards virtual engagement. The guests emphasize the importance of tactical planning and motivation strategies for MSL teams, along with lifelong learning and the benefits of MSL coaching. The episode concludes with tips for top performance and the necessity of continuous learning and adaptability in the field.
This episode is sponsored by IQVIA. www.iqvia.com
Linda Traylor, Sr Principal and Rina Patel, Director Medical Affairs at IQVIA discuss KPIs and the importance of qualitative Outcomes
Linda and Rina share…
👉 What are KPIs and why are they so important
👉 Does medical affairs have standards for KPIs
👉 Their approach to establishing KPIs and what is most important to track
👉 How medical affairs leaders align quantitative metrics with qualitative ones
👉 What qualitative outcomes should MSLs hope to achieve and why
👉 How the value of MSLs should be measured from a company perspective
MSL profession, networking in medical affairs, KPI integration, virtual engagement strategies, MSL coaching benefits
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Alyson Evans
Podcast
MSL Talk: Tom Caravela, Doug Yau
Emotional Intelligence and the MSL: More Important than EVER
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO